Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832026 · ClinicalTrials.gov registry record
Trans Nasal Insufflation for the Treatment of Snoring
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 11
- Enrollment target
NCT00832026: Completed study, sponsored by Johns Hopkins University.
NCT00832026 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832026 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea. People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repetitive closure of the throat. The most common form of treatment for sleep apnea is continuous positive airway pressure (CPAP) therapy. While CPAP therapy remains the simplest and most effective treatment for snoring and sleep apnea, patients have to wear a nasal mask throughout the night. For this reason, patients often have difficulty sticking to therapy. Participants enrolled in this study will spend 3-nights in a sleep laboratory. In all nights, the investigators will monitor your sleep and your breathing throughout the night. The investigators will apply several electrodes (sensors) to your scalp and face to monitor your sleep and breathing, and other sensors to your chest, abdomen, cheek, and a finger to monitor your breathing and oxygen level.
Interventions
- DEVICE Trans Nasal Insufflation (TNI) [nasal canula]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832026
The ClinicalTrials.gov registry entry for NCT00832026 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trans Nasal Insufflation (TNI) [nasal canula] is the first listed.
NCT00832026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832026 about?
NCT00832026 is a clinical study titled "Trans Nasal Insufflation for the Treatment of Snoring". This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea. People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repe...
What is the current status of trial NCT00832026?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2004-07. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00832026?
The interventions under investigation include: Trans Nasal Insufflation (TNI) [nasal canula] (DEVICE).
Who is sponsoring clinical trial NCT00832026?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.